Subtipos histopatológicos de linfoma de Hodgkin (clasificación de la OMS)

Subtipos histopatológicos de linfoma de Hodgkin (clasificación de la OMS)

Tipo histológico

Aspecto morfológico

Inmunogenotipo de las células tumorales

Clásico

Esclerosis nodular

Tejido fibroso denso que rodea nódulos de tejido de Hodgkin

CD15+, CD30+, CD20–

Celularidad mixta

Cantidad moderada de células de Reed-Sternberg con un infiltrado basal mixto

CD15+, CD30+, CD20–

Rico en linfocitos

Escasas células de Reed-Sternberg

Numerosos linfocitos B

CD15+, CD30+, CD20–

Depleción linfocítica

Numerosas células de Reed-Sternberg

Fibrosis extensa

CD15+, CD30+, CD20–

Nodular con predominio linfocítico*

Pocas células neoplásicas (células linfocíticas o histiocítcas o ambas)

Muchos linfocitos B pequeños

Patrón nodular

CD15–, CD30–, CD20+, EMA+

EMA = antígeno de membrana epitelial.

* Nodular lymphocyte-predominant Hodgkin lymphoma has been reclassified as an non-Hodgkin B-cell lymphoma by the International Consensus Classification and is called nodular lymphocyte predominant B-cell lymphoma (see Campo E, Jaffe ES, Cook JR, et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee [published correction appears in Blood 2023 Jan 26;141(4):437]. Blood 2022;140(11):1229-1253. doi:10.1182/blood.2022015851). 

EMA = antígeno de membrana epitelial.

* Nodular lymphocyte-predominant Hodgkin lymphoma has been reclassified as an non-Hodgkin B-cell lymphoma by the International Consensus Classification and is called nodular lymphocyte predominant B-cell lymphoma (see Campo E, Jaffe ES, Cook JR, et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee [published correction appears in Blood 2023 Jan 26;141(4):437]. Blood 2022;140(11):1229-1253. doi:10.1182/blood.2022015851). 

En estos temas